Jay A Motola, MD Email Jay Motola
- ASSOCIATE PROFESSOR | Urology
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Brooklyn
- Physician Office 212-523-7016 212-523-7016
Jay Motola, MD, is a board certified urologist and attending physician, Department of Urology, Mount Sinai West, and Assistant Professor of Urology, Icahn School of Medicine at Mount Sinai. Dr. Motola is a summa cum laude, Phi Beta Kappa graduate of Boston University, and earned his medical degree at the State University of New York at Stony Brook. He completed his general surgery and urology residencies at Long Island Jewish Medical Center. Dr. Motola is a fellow of the American College of Surgeons and a member of the Endourology Society. His clinical interests are ablative treatments for prostate cancer urinary incontinence, minimally invasive treatments for kidney stones, and urinary prosthetics. In addition, Dr. Motola has an interest and deep understanding of the socioeconomics of medicine. He is extremely active in the American Urological Association, and is the national chairman for Practice Management. He serves on the AUA’s IT committee and the Health Policy Council, and is presently secretary of the New York Section of the American Urological Association.
Dr. Motola's Patient Stories:
American Board of Urology
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Congenital Kidney Disease
- Frequent Urination
- Kidney Stones
- Neurogenic Bladder
- Prostate Cancer
- Prostate Cancer Screening
MD, SUNY at Stony Brook
BA, Boston Univeristy
MD, SUNY at Stony Brook School of Medicine
, Long Island Jewish Medical Center
Long Island Jewish Medical Center
Theckumparampil N, Elsamra SE, Carons A, Salami SS, Leavitt D, Kavoussi A, Motola J, Smith A, Okeke Z. Symptoms after removal of ureteral stents. Journal of endourology / Endourological Society 2015 Feb; 29(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Motola during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Allied Urological
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.